Bilimsel çalışmalar

Uzm. Dr. Şaban Seçmeler

41 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-15725-9 PMID 41691201 Açık erişimli tam metinKaynak: OpenAlex

  2. AI-augmented pharmacovigilance for cardio-oncology: FDR- controlled disproportionality and anomaly detection of antineoplastic-associated cardiac events in FAERS (2015 Q1–2025 Q4)

    Research Square, 2026

    DOI 10.21203/rs.3.rs-8961206/v1 Açık erişimli tam metinKaynak: OpenAlex

  3. Radiation-Induced Pleomorphic Dermal Sarcoma of the Chest Wall 25 Years After Breast Cancer Radiotherapy: A Case Report and Literature Review

    Cureus, 2026

    DOI 10.7759/cureus.112878 PMID 42605482 Açık erişimli tam metinKaynak: OpenAlex

  4. Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-29276-9 PMID 41315659 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  5. Bevacizumab Efficacy and Tolerability in Patients with Metastatic Platinum-Sensitive Ovarian Cancer Beyond Progression

    Cancer Management and Research, 2025

    DOI 10.2147/cmar.s531276 PMID 40861079 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  6. Detecting subclinical cardiotoxicity during immune checkpoint inhibitor therapy: a combined GLS and ECG repolarization analysis.

    Frontiers in oncology, 2025

    DOI 10.3389/fonc.2025.1615209 PMID 40697379 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  7. Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

    BMC Cancer, 2024

    DOI 10.1186/s12885-023-11783-5 PMID 38166764 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  8. Perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in gastric cancer: Pathological regression grade and its relationship to clinical outcome

    Indian Journal of Cancer, 2024

    DOI 10.4103/ijc.ijc_1283_20 PMID 39960699 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  9. Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380 Açık erişimli tam metinKaynak: OpenAlex

  10. Evaluation of ixabepilone efficacy and tolerability in metastatic breast cancer

    Medicine, 2024

    DOI 10.1097/md.0000000000040649 PMID 39809199 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  11. Tüm Vücut Hipertermi (Whole Body Hyperthermia)

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380.c14026 Kaynak: OpenAlex

  12. Major and minor salivary gland cancers: A multicenter retrospective study

    Head & Neck, 2023

    DOI 10.1002/hed.27376 PMID 37084179 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  13. Are Syrian refugee breast cancer patients diagnosed at advanced stage and do they have treatment delays?

    Future Oncology, 2023

    DOI 10.2217/fon-2022-1093 PMID 37170860 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  14. Pretreatment Modified Glasgow Prognostic Score for Predicting Prognosis and Survival in Elderly Patients with Gastric Cancer Treated with Perioperative FLOT

    Nutrients, 2023

    DOI 10.3390/nu15194156 PMID 37836440 9 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  15. Efficacy of Imatinib on Advanced and Refractory Desmoid Tumors: A Retrospective Study

    Journal of Oncological Sciences, 2022

    DOI 10.37047/jos.2021-87391 Açık erişimli tam metinKaynak: OpenAlex

  16. Are Syrian refugees breast cancer patients diagnosed at advanced stage? Is it a myth or reality?

    Research Square, 2022

    DOI 10.21203/rs.3.rs-2195867/v1 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  17. The Relationship Between Spot Urinary Protein/Creatinine Ratio and HbA1C, Metabolic Parameters and Other Complications in Patients with Type 2 Diabetes

    Eurasian Journal of Medical Advances, 2022

    DOI 10.14744/ejma.2022.29392 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  18. Efficacy of Trastuzumab and Potential Risk Factors on Survival in Patients with HER2-Positive Metastatic Gastric Cancer

    Future Oncology, 2021

    DOI 10.2217/fon-2021-0398 PMID 34323116 2 atıf (Europe PMC) Kaynak: OpenAlex

  19. Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study

    European Journal of Breast Health, 2021

    DOI 10.4274/ejbh.galenos.2020.6346 PMID 33870111 11 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  20. The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy

    Cureus, 2021

    DOI 10.7759/cureus.14639 PMID 34046274 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  21. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study

    Tumori Journal, 2021

    DOI 10.1177/03008916211037739 PMID 34365852 5 atıf (Europe PMC) Kaynak: OpenAlex

  22. The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155219898504 PMID 31955700 3 atıf (Europe PMC) Kaynak: OpenAlex

  23. Does the Waiting Period for Genetic Tests Affect the Prognosis in Chemotherapy-Treated de novo Metastatic Non-Small Cell Lung Cancer Patients without a Driver Mutation?

    Oncology Research and Treatment, 2020

    DOI 10.1159/000511773 PMID 33242864 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  24. Adrenocortical Carcinoma:Single Center Experience

    Van Yüzüncü Yıl University Academic Data Management System, 2020

    Kaynak: OpenAlex

  25. Prognostic Significance of Mean Platelet Volume on Local Advanced Non-Small Cell Lung Cancer Managed with Chemoradiotherapy

    Scientific Reports, 2019

    DOI 10.1038/s41598-019-40589-4 PMID 30850724 16 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  26. The effects of diabetes and fasting plasma glucose on treatment of breast cancer with neoadjuvant chemotherapy

    Current Problems in Cancer, 2019

    DOI 10.1016/j.currproblcancer.2019.05.007 PMID 31200961 12 atıf (Europe PMC) Kaynak: OpenAlex

  27. The effect of body mass index on location of recurrence and survival in early-stage colorectal cancer

    Journal of Cancer Research and Therapeutics, 2019

    DOI 10.4103/jcrt.jcrt_326_18 PMID 33380674 12 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  28. Efficacy and tolerability of adjuvant therapy in ≥70-year-old patients with T3N0M0 colorectal cancer: An observational study

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155219865008 PMID 31366267 3 atıf (Europe PMC) Kaynak: OpenAlex

  29. The effects of fulvestrant treatment on hormone receptor-positive metastatic breast cancer

    The European Research Journal, 2019

    DOI 10.18621/eurj.470881 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  30. Non-urothelial Bladder Cancers: Single Center Experience

    European Archives of Medical Research, 2019

    DOI 10.4274/eamr.galenos.2019.21931 Açık erişimli tam metinKaynak: OpenAlex

  31. Adrenocortical Carcinoma: Single Center Experience

    European Archives of Medical Research, 2019

    DOI 10.4274/eamr.25744 Açık erişimli tam metinKaynak: OpenAlex

  32. Mide Kanserlerinde İmmünoterapiler: PD-1 ve PD-L1 İnhibitörleri

    Turkiye Klinikleri Medical Oncology - Special Topics, 2019

    Kaynak: OpenAlex

  33. Factors Affecting Survival in Neuroendocrine Tumors: A 15-Year Single Center Experience

    Asian Pacific Journal of Cancer Prevention, 2018

    DOI 10.31557/apjcp.2018.19.12.3597 PMID 30583688 9 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  34. Prognostic significance of primary tumor localization in stage II and III colon cancer

    World Journal of Gastrointestinal Oncology, 2018

    DOI 10.4251/wjgo.v10.i11.410 PMID 30487952 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  35. Fulvestrant efficacy in artificial menopausal hormone receptor positive and HER 2 negative metastatic breast cancer patients under 50 years old.

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.e13000 Kaynak: OpenAlex

  36. Opere erken evre kolon kanserinde vücut kitle indeksinin nüks lokalizasyonu, hastalıksız sağkalım ve genel sağkalım etkisi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Kaynak: OpenAlex

  37. Erken evre(1-3) kolon kanseri hastalarında tümör lokalizasyonunun hastalıksı sağkalım ve genel sağkalıma etkisi:tek merkez deneyimi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Kaynak: OpenAlex

  38. Pleomorfik Sarkom tanılı hastada ifosfamid toksisitesi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Kaynak: OpenAlex

  39. Opere iyi diferansiye Gastroenteropankreatik nöroendokrin tümörlerde Lenf nodu tutulumunun ve primer tümör lokalizasyonunun Klinik önemi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Kaynak: OpenAlex

  40. Nüks Apendiks Adenokarsinoid Tümörü:Olgu Sunumu ve Literatür Güncellemesi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Kaynak: OpenAlex

  41. Prognostic significance of high free T4 and low free T3 levels in non-thyroidal illness syndrome

    European Journal of Internal Medicine, 2018

    DOI 10.1016/j.ejim.2018.07.018 PMID 30029851 18 atıf (Europe PMC) Kaynak: ORCID